menu search

Got $1,000? these 2 stocks could be bargain buys for 2023 and beyond

abbvie has good reasons for investors to take a close look at the stock, even though its best-selling d...

October 26, 2023, 7:50 am

Why abbvie (abbv) is poised to beat earnings estimates again

abbvie (ABBV) has an impressive earnings surprise history and currently possesses the right combination...

October 25, 2023, 1:32 pm

abbvie (abbv) sees a more significant dip than broader market: some facts to know

In the latest trading session, abbvie (ABBV) closed at $144.73, marking a -1.03% move from the previous...

October 23, 2023, 6:47 pm

Earnings preview: abbvie (abbv) q3 earnings expected to decline

abbvie (ABBV) doesn't possess the right combination of the two key ingredients for a likely earnings be...

October 20, 2023, 11:17 am

Is abbvie stock too pricey to touch right now?

abbvie's valuation is elevated, though it has no major catalysts coming up. It's also seeing sales of i...

October 19, 2023, 7:05 am

abbvie: the humira loss may be fully priced in after all

The US FDA has already approved two directly interchangeable biosimilars to ABBV's Humira, namely Boehringer Ingelheim's Cyltezo and PFE's ABRILADA. T...

October 18, 2023, 11:00 am

abbvie inc. (abbv) is attracting investor attention: here is what you should know

Zacks.com users have recently been watching abbvie (ABBV) quite a bit. Thus, it is worth knowing the fa...

October 18, 2023, 10:31 am

abbvie: q2 success sets the stage for consistent growth

abbvie is a leading pharmaceutical company with a strong history and a diverse portfolio of products. T...

October 17, 2023, 1:58 pm

abbvie: why you should pay attention to this high-yielding dividend king (rating downgrade)

Dividend Kings are the most battle-tested dividend payers on Wall Street, with abbvie being just one of...

October 17, 2023, 9:20 am

abbvie (abbv) stock sinks as market gains: here's why

abbvie (ABBV) concluded the recent trading session at $147.23, signifying a -0.49% move from its prior ...

October 16, 2023, 6:47 pm

abbvie: successfully navigating humira's patent cliff with 4% yield and 270% dgr since 2014

Since its spin-off from Abbott Labs, abbvie has delivered outstanding performance, surpassing both its ...

October 16, 2023, 10:44 am

3 dividend growth stocks you can buy and hold forever

abbvie boasts a stellar dividend track record and a resilient business. Eli Lilly's dividend yield migh...

October 14, 2023, 6:52 am

abbvie's (abbv) rinvoq meets key goal in phase ii vitiligo study

abbvie (ABBV) meets the primary goal in the phase II study evaluating Rinvoq in the treatment of adult ...

October 13, 2023, 8:16 am

abbvie (abbv) rises yet lags behind market: some facts worth knowing

In the most recent trading session, abbvie (ABBV) closed at $149.11, indicating a +0.59% shift from the...

October 9, 2023, 6:47 pm

Should you load up on this 1 dividend stock?

abbvie has an impressive streak of consecutive dividend increases. Its underlying business is solid des...

October 6, 2023, 10:15 am

3 high-yielding dividend growth stocks that have increased their payouts by 50% in 5 years

abbvie, McDonald's, and Comcast all provide investors with above-average yields. They have been increas...

October 4, 2023, 9:53 am

Dividend growth predictions for 15 companies announcing annual boosts in october

Fifteen long-term dividend growth companies, abbvie among them, will announce their annual increases in...

October 2, 2023, 7:23 am

abbvie inc. (abbv) is a trending stock: facts to know before betting on it

Zacks.com users have recently been watching abbvie (ABBV) quite a bit. Thus, it is worth knowing the fa...

September 29, 2023, 10:31 am

abbvie's blood cancer combo therapy fails in late-stage study

abbvie said on Friday a late-stage study of its experimental combination therapy failed to show meaning...

September 29, 2023, 8:05 am

Biogen inc. (biib) management presents at decentralized clinical trials in focus conference (transcript)

Biogen Inc. (NASDAQ:BIIB ) Decentralized Clinical Trials in Focus Conference September 26, 2023 10:00 AM ET Company Participants Stephanie Manson Brow...

September 26, 2023, 5:17 pm


Search within

Pages Search Results: